NOVN Stock: Novan, Inc. Stock Price, Analysis & Insights
Get live NOVN stock price $0.09, comprehensive Novan, Inc. stock analysis, charts, news, and expert forecast. Real-time NOVN stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Novan, Inc. operates as a pre-commercial pharmaceutical entity specializing in nitric oxide-derived therapies for dermatological and anti-infective conditions. The company boasts a robust clinical-stage pipeline featuring several topical drug candida...
Company Information
- CEO
- Paula Brown Stafford
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 90
Contact Information
- Website
- https://www.novan.com
- Address
- 4020 Stirrup Creek Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -0.04) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Novan, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Novan, Inc.
- ⚠Investors should consider how Novan, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
2.64M
P/E Ratio (TTM)
-0.11
Beta
-0.04
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare NOVN with peer companies:
- Price
- $0.18
- Market cap
- 2.98M
- Price
- $0.04
- Market cap
- 2.95M
- Price
- $8.22
- Market cap
- 2.61M
- Price
- $8.50
- Market cap
- 12.59M
- Price
- $0.29
- Market cap
- 1.98M
- Price
- $0.25
- Market cap
- 2.39M
- Price
- $13.66
- Market cap
- 355.14M
- Price
- $11.91
- Market cap
- 152.10M
- Price
- $0.03
- Market cap
- 3.14M
- Price
- $0.20
- Market cap
- 3.44M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.